ALPINE 4 HOLDINGS INC (ALPP)

US02083E2046 - Common Stock

0.1951  -0.14 (-42.07%)

After market: 0.2175 +0.02 (+11.48%)

Fundamental Rating

1

Taking everything into account, ALPP scores 1 out of 10 in our fundamental rating. ALPP was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. ALPP has a bad profitability rating. Also its financial health evaluation is rather negative. ALPP is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

In the past year ALPP has reported negative net income.
ALPP had a positive operating cash flow in the past year.
In the past 5 years ALPP always reported negative net income.
In the past 5 years ALPP always reported negative operating cash flow.

1.2 Ratios

ALPP's Return On Assets of -54.39% is on the low side compared to the rest of the industry. ALPP is outperformed by 86.40% of its industry peers.
ALPP has a worse Return On Equity (-272.93%) than 92.00% of its industry peers.
Industry RankSector Rank
ROA -54.39%
ROE -272.93%
ROIC N/A
ROA(3y)-13.87%
ROA(5y)-18.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 19.22%, ALPP is doing worse than 68.80% of the companies in the same industry.
ALPP's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALPP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.47%
GM growth 5Y-6.43%

0

2. Health

2.1 Basic Checks

ALPP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALPP has been increased compared to 1 year ago.
The number of shares outstanding for ALPP has been increased compared to 5 years ago.
The debt/assets ratio for ALPP has been reduced compared to a year ago.

2.2 Solvency

ALPP has an Altman-Z score of -1.37. This is a bad value and indicates that ALPP is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.37, ALPP is not doing good in the industry: 80.80% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.45 is on the high side and indicates that ALPP has dependencies on debt financing.
With a Debt to Equity ratio value of 1.45, ALPP is not doing good in the industry: 91.20% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.45
Debt/FCF N/A
Altman-Z -1.37
ROIC/WACCN/A
WACC5.79%

2.3 Liquidity

ALPP has a Current Ratio of 0.86. This is a bad value and indicates that ALPP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ALPP (0.86) is worse than 92.00% of its industry peers.
A Quick Ratio of 0.43 indicates that ALPP may have some problems paying its short term obligations.
With a Quick ratio value of 0.43, ALPP is not doing good in the industry: 92.80% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.43

3

3. Growth

3.1 Past

The earnings per share for ALPP have decreased strongly by -142.16% in the last year.
ALPP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.70%.
The Revenue has been growing by 65.99% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-142.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-831.25%
Revenue 1Y (TTM)15.7%
Revenue growth 3Y54.8%
Revenue growth 5Y65.99%
Sales Q2Q%-6.87%

3.2 Future

The Earnings Per Share is expected to decrease by -14.02% on average over the next years. This is quite bad
ALPP is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -23.38% yearly.
EPS Next Y-57.5%
EPS Next 2Y-14.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.24%
Revenue Next 2Y-23.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALPP. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALPP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

ALPP's earnings are expected to decrease with -14.02% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.02%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALPP!.
Industry RankSector Rank
Dividend Yield N/A

ALPINE 4 HOLDINGS INC

NASDAQ:ALPP (10/17/2024, 9:22:20 PM)

After market: 0.2175 +0.02 (+11.48%)

0.1951

-0.14 (-42.07%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.81M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -54.39%
ROE -272.93%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 19.22%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 1.45
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.86
Quick Ratio 0.43
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-142.16%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-57.5%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)15.7%
Revenue growth 3Y54.8%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y